Toposecuencia de suelos en el piso montano del Parque Natural del Moncayo

El presente trabajo pretende caracterizar los suelos formados sobre areniscas cuarcítica en el piso montano del Parque Natural del Moncayo (Zaragoza), a lo largo de una toposecuencia para diagnosticar su estado de desarrollo. El Parque Natural del Moncayo es una zona que ha recibido atención desde varios puntos de vista: geomorfológico (Pellicer, 1996), y botánico (Ballarín, 1996). A pesar de todo, es escasa la información disponible sobre sus suelos, teniendo que remontarse a las primeras descripciones de Guerra (1968). Se abrieron un total de cinco perfiles edáficos a lo largo del piso montano en la vertiente noroeste. Posteriormente re caracterizaron las propiedades macromorfológicas (C.B.D.S.A., 1983), físicas y químicas (M.A.P.A., 1994), y biológicas (Jabiol, 2007). Un factor muy influyente es la altitud, apreciándose que el proceso de la podsolización está presente, y es gradual a lo largo de la ladera (Carceller y Vallejo, 1996). Las acumulaciones de hierro y aluminio a lo largo de la toposecuencia, los bajos niveles de pH, la gran cantidad de materia orgánica presente, la elevada pedregosidad, y las texturas francas y franco arenosas, son algunas de las características de estos suelos. Los perfiles estudiados fueron clasificados según World Reference Base (2014) como podzoles álbico, cambisoles dístricos y umbrisoles esquelético y según Soil Survey Staff (2014) como typic haplorthod, spodic dystrudept, typic dystrupet y humic dystrudept

Capacitive platform for real-time wireless monitoring of liquid wicking in a paper strip

Understanding the phenomenon of liquid wicking in porous media is crucial for various applications, including the transportation of fluids in soils, the absorption of liquids in textiles and paper, and the development of new and efficient microfluidic paper-based analytical devices (μPADs). Hence, accurate and real-time monitoring of the liquid wicking process is essential to enable precise flow transport and control in microfluidic devices, thus enhancing their performance and usefulness. However, most existing flow monitoring strategies require external instrumentation, are generally bulky and unsuitable for portable systems. In this work, we present a portable, compact, and cost-effective electronic platform for real-time and wireless flow monitoring of liquid wicking in paper strips. The developed microcontroller-based system enables flow and flow rate monitoring based on the capacitance measurement of a pair of electrodes patterned beneath the paper strip along the liquid path, with an accuracy of 4 fF and a full-scale range of 8 pF. Additionally to the wired transmission of the monitored data to a computer via USB, the liquid wicking process can be followed in real-time via Bluetooth using a custom-developed smartphone application. The performance of the capacitive monitoring platform was evaluated for different aqueous solutions (purified water and 1 M NaCl solution), various paper strip geometries, and several custom-made chemical valves for flow retention (chitosan-, wax-, and sucrose-based barriers). The experimental validation delivered a full-scale relative error of 0.25%, resulting in an absolute capacitance error of ±10 fF. In terms of reproducibility, the maximum uncertainty was below 10 nl s−1 for flow rate determination in this study. Furthermore, the experimental data was compared and validated with numerical analysis through electrical and flow dynamics simulations in porous media, providing crucial information on the wicking process, its physical parameters, and liquid flow dynamics

The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

Background: Mortality due to COVID-19 is high, especially in patients requiring mechanical ventilation. The purpose of the study is to investigate associations between mortality and variables measured during the first three days of mechanical ventilation in patients with COVID-19 intubated at ICU admission. Methods: Multicenter, observational, cohort study includes consecutive patients with COVID-19 admitted to 44 Spanish ICUs between February 25 and July 31, 2020, who required intubation at ICU admission and mechanical ventilation for more than three days. We collected demographic and clinical data prior to admission; information about clinical evolution at days 1 and 3 of mechanical ventilation; and outcomes. Results: Of the 2,095 patients with COVID-19 admitted to the ICU, 1,118 (53.3%) were intubated at day 1 and remained under mechanical ventilation at day three. From days 1 to 3, PaO2/FiO2 increased from 115.6 [80.0-171.2] to 180.0 [135.4-227.9] mmHg and the ventilatory ratio from 1.73 [1.33-2.25] to 1.96 [1.61-2.40]. In-hospital mortality was 38.7%. A higher increase between ICU admission and day 3 in the ventilatory ratio (OR 1.04 [CI 1.01-1.07], p = 0.030) and creatinine levels (OR 1.05 [CI 1.01-1.09], p = 0.005) and a lower increase in platelet counts (OR 0.96 [CI 0.93-1.00], p = 0.037) were independently associated with a higher risk of death. No association between mortality and the PaO2/FiO2 variation was observed (OR 0.99 [CI 0.95 to 1.02], p = 0.47). Conclusions: Higher ventilatory ratio and its increase at day 3 is associated with mortality in patients with COVID-19 receiving mechanical ventilation at ICU admission. No association was found in the PaO2/FiO2 variation

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe

Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study

Background Early mobilisation (EM) is an intervention that may improve the outcome of critically ill patients. There is limited data on EM in COVID-19 patients and its use during the first pandemic wave. Methods This is a pre-planned subanalysis of the ESICM UNITE-COVID, an international multicenter observational study involving critically ill COVID-19 patients in the ICU between February 15th and May 15th, 2020. We analysed variables associated with the initiation of EM (within 72 h of ICU admission) and explored the impact of EM on mortality, ICU and hospital length of stay, as well as discharge location. Statistical analyses were done using (generalised) linear mixed-effect models and ANOVAs. Results Mobilisation data from 4190 patients from 280 ICUs in 45 countries were analysed. 1114 (26.6%) of these patients received mobilisation within 72 h after ICU admission; 3076 (73.4%) did not. In our analysis of factors associated with EM, mechanical ventilation at admission (OR 0.29; 95% CI 0.25, 0.35; p = 0.001), higher age (OR 0.99; 95% CI 0.98, 1.00; p ≤ 0.001), pre-existing asthma (OR 0.84; 95% CI 0.73, 0.98; p = 0.028), and pre-existing kidney disease (OR 0.84; 95% CI 0.71, 0.99; p = 0.036) were negatively associated with the initiation of EM. EM was associated with a higher chance of being discharged home (OR 1.31; 95% CI 1.08, 1.58; p = 0.007) but was not associated with length of stay in ICU (adj. difference 0.91 days; 95% CI − 0.47, 1.37, p = 0.34) and hospital (adj. difference 1.4 days; 95% CI − 0.62, 2.35, p = 0.24) or mortality (OR 0.88; 95% CI 0.7, 1.09, p = 0.24) when adjusted for covariates. Conclusions Our findings demonstrate that a quarter of COVID-19 patients received EM. There was no association found between EM in COVID-19 patients' ICU and hospital length of stay or mortality. However, EM in COVID-19 patients was associated with increased odds of being discharged home rather than to a care facility. Trial registration ClinicalTrials.gov: NCT04836065 (retrospectively registered April 8th 2021)

Sweet Cherry (<i>Prunus avium</i> L.) Cracking during Development on the Tree and at Harvest: The Impact of Methyl Jasmonate on Four Different Growing Seasons

Rainfall occurring during the developmental stages of sweet cherries on the tree can lead to significant preharvest losses, primarily due to fruit cracking. Certain cultivars exhibit a higher susceptibility to such losses, particularly when persistent rains coincide with advanced phenological stages. The current study aims to investigate the efficacy of preharvest methyl jasmonate (MeJA) applications at harvest and during distinct developmental ripening stages in mitigating sweet cherry cracking at harvest and on-tree ripening. Preharvest foliar applications of 0.5 mM MeJA were applied across various sweet cherry cultivars, including ‘Prime Giant’, ‘Early Lory’, ‘Sweetheart’, and ‘Staccato’. By conducting this experiment over four growing seasons, we evaluated the impact of this natural elicitor on the cracking tolerance of these cultivars. The results of our analysis indicate that MeJA preharvest treatments effectively reduce fruit cracking, enhancing abiotic stress tolerance. Additionally, these treatments induce a general delay in fruit ripening on the tree across the examined cultivars. This delayed ripening effect is reflected in several quality parameters at harvest, such as the fruit firmness, external colour, total soluble solids, and total acidity. These parameters in the MeJA-treated fruit were delayed compared to the control fruit or remained unaffected for the total acidity. Conversely, the MeJA treatments delayed the accumulation of total polyphenols, exhibiting a minimal impact on reducing pedicel browning. The enhanced tolerance to cracking and delayed ripening attributed to the MeJA preharvest treatments could be helpful for plot management. Consequently, these MeJA-based preharvest treatments hold potential as valuable tools in adapting to climate change and mitigating abiotic stress in sweet cherry

Table_6_Endometrial whole metabolome profile at the receptive phase: influence of Mediterranean Diet and infertility.xlsx

IntroductionSeveral metabolite classes have been identified in human endometrium, including lipids, nucleotides, amino acids, organic acids, and sugars. The first studies suggest the importance of metabolites in endometrial functions, as imbalance in uterine metabolites has been associated with low implantation rate and endometriosis. Nevertheless, most of studies have put emphasis on specific metabolite classes, and we lack the knowledge of the whole metabolome composition in human uterus. Further, a healthy dietary pattern has been shown to potentially protect against different endometrial dysfunctions and is a potential modulator of metabolomic composition and, consequently, the intrauterine microenvironment. The Mediterranean Diet (MD), characterized by a high intake of fruits, vegetables, cereals, nuts, legumes, fish, and olive oil, and a low consumption of meat, dairy products, and processed foods, has been associated with a wide range of benefits for health. Indeed, the MD pattern has displayed a beneficial role in endometriosis management and fertility; however, the relationship between the MD and the endometrial metabolome is still unknown. In our study, we set out to analyze receptive-phase endometrial metabolome profiles among women with infertility and their associations with MD.MethodsThe study included women with male factor infertility (n=8), unexplained infertility (n=10), recurrent implantation failure (n=14), and endometriosis (n=13). The endometrial metabolome was analyzed with ultrahigh-performance liquid chromatography-tandem mass spectroscopy (UPLC–MS/MS). The MD adherence of the participants was assessed using the 14-point MEDAS questionnaire of adherence to the MD. ResultsWe provide the whole metabolome profile of the endometrium, where 925 different metabolites were identified. Among these metabolites, lipids comprised the largest part, where polyunsaturated fatty acids (PUFAs) prevailed. Women with endometriosis and recurrent implantation failure were found to have lower levels of PUFAs compared to women with male factor and unexplained infertility (i.e., no clear endometrial alterations), identifying a metabolome profile associated with infertility diagnoses where altered endometrial functions are suspected. Moreover, MD adherence seemed to be associated with the endometrial metabolomic profile in a manner dependent on the health status of the uterus. ConclusionThe study findings provide insight into the molecular background of female infertility and lead to identification of potential molecular biomarkers and possibilities for modulating the endometrial microenvironment and, thereby, endometrial functions involved in embryo implantation and infertility. </p